Press Releases

MAKING THE PRESS

FDA Approves First-of-its-Kind Product for Treatment of Melanoma

FDA Approves First-of-its-Kind Product for Treatment of Melanoma

The physicians, staff, and patients at Mary Crowley Cancer Research are proud to have collaborated with BioVex to help develop and lead the pivotal Phase II trial of the first-of-its-kind cancer-specific, immune-enhancing herpes virus for patients with melanoma, which was just approved by the FDA. Read Full Story Here.

Hockey Fights Cancer 2015

Hockey Fights Cancer 2015

Mary Crowley Cancer Research “teams up” with Dallas Stars Foundation to fight cancer. Read Full Story Here.

Celebrate Life Sip & Shop

Celebrate Life Sip & Shop

Mary Crowley Cancer Research hosted the “Celebrate Life Sip & Shop” on Wednesday, October 21, 2015. Read Full Story Here.

First Baptist Academy & Saints for a Cure Raise Funds for Breast Cancer Research

First Baptist Academy & Saints for a Cure Raise Funds for Breast Cancer Research

The First Baptist Academy of Dallas paid tribute to Julie Shoemake, one of their Lower School principals, on October 9, 2015. Read Full Story Here.

Big Hope 1 Carries More Than Grain

Big Hope 1 Carries More Than Grain

Dr. John Nemunaitis, Executive Medical Director at Mary Crowley, is scheduled to present at World Conference on Lung Cancer, September 8, 2015. Read Full Story Here.

Celebrating 20 Years